GateHouse Bio (fka sRNAlytics)
ActiveAn RNA therapeutic company
What it does
WE ARE GATEHOUSE BIO We believe there is an RNA code that drives every disease Our mission is to find that code and use it to develop effective therapeutics Our Code-Breaker™ platform uses AI to decode the landscape of small RNAs (sRNAs) and digitally design biomarker-guided precision oligonucleotide therapeutics We are currently developing our lead [ ]
Next to it in Healthcare and bio · RNA therapeutic development
- Magellan Life SciencesSOSV SOSV IndieBio RebelBio 05
Discovering, deciphering, and developing unique plant proteins using synthetic biology
- Dorian TherapeuticsY Combinator S18
New therapeutics to rejuvenate tissue and treat age-related diseases
- Diadem BiotherapeuticsSOSV SOSV IndieBio 09
Engineering the next class of biologics to treat chronic inflammatory diseases
- Intrinsic Medicine (fka Lupa Bio)SOSV SOSV IndieBio 09
Developing the next generation of essential, disease-modifying medicines
- A-Bio MaterialsPlug and Play
A-Bio Materials is a life science research and development company that develops new biomaterials.
- Multerra BioPlug and Play
Multerra Bio is a business enterprise that develops the research program in various clinical treatments.
- ルクサナバイオテク株式会社Plug and Play
Luxana Biotech is established to contribute to medical treatment for suffering patients, .
- ANA TherapeuticsSOSV SOSV Portfolio: Po Bronson
Investigating niclosamide as a treatment for COVID-19